Cancer Patients not getting live-saving flu and pneumonia shotsOctober 29, 2007Although flu and pneumonia can be lethal for cancer patients, more than one quarter of patients undergoing radiation therapy are not complying with national guidelines to be vaccinated against these potentially life-threatening yet preventable illnesses, according to a study presented October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles. While Centers for Disease Control and Prevention guidelines and the Joint Commission recommend an annual flu (influenza) vaccine for cancer patients aged 50 years or older, 25 percent of patients 50 years or older reported never having received the flu vaccine. Similarly, the pneumonia (pneumococcus) vaccine is recommended to all cancer patients 65 year or older; however, over one-third (36 percent) of cancer patients in this age range reported never having received the vaccine. Cancer patients are at a higher risk of acquiring and dying from these illnesses due to a weaker immune system, among other factors. Three reasons accounted for almost 80 percent of why patients didn't receive either vaccine: Patients either believed they didn't need the vaccines, they didn't know about the recommended vaccination guidelines or their physicians didn't recommend the vaccines. While 44 percent of patients who received either vaccine reported that they were asked or informed about these vaccines by their family physicians or internists, only seven percent reported being asked or informed by their oncologists. "People undergoing cancer treatment and their loved ones should ask their oncologists about these vaccines. They are a very simple, yet very effective, way for people living with cancer to extend their lives," said Neha Vapiwala, M.D., a study author and a radiation oncologist at the Hospital of the University of Pennsylvania in Philadelphia. "Oncologists have the opportunity to talk to patients about recommended vaccines during their frequent interactions with patients, whether it be before, during, or after cancer therapy. This discussion could result in better cancer care and ultimately save lives." This was the first study done to find out whether cancer patients receiving radiation therapy complied with national vaccination guidelines. The anonymous study asked 207 patients from August 2006 to January 2007 about whether they received the flu and pneumococcus vaccines. Those who reported receiving neither vaccine were asked further questions about the reasons why they didn't receive them. American Society for Therapeutic Radiology and Oncology |
|||||||||||||||||||||
| Related Cancer Patient Current Events and Cancer Patient News Articles NIH study reveals new genetic culprit in deadly skin cancer Drawing on the power of DNA sequencing, National Institutes of Health researchers have identified a new group of genetic mutations involved in the deadliest form of skin cancer, melanoma. 2 software tools that improve identification of cancer biomarkers earn certification The explosive growth of genomic and proteomic data has ushered in a new era of molecular medicine in which cancer detection, diagnosis and treatment are tailored to each individual's molecular profile. Human cells secrete cancer-killing protein, UK study finds Human cells are able to secrete a cancer-killing protein, scientists at the University of Kentucky's Markey Cancer Center have found. New technique could sustain cancer patients' fertility Researchers funded by the National Institutes of Health have completed a critical first step in the eventual development of a technique to retain fertility in women with cancer who require treatments that might otherwise make them unable to have children. New technique could save cancer patients' fertility The tiny translucent egg nestled in the special laboratory gel was a mere 30 days old, but its four-week birthday caused researchers to quietly celebrate. Report: Prostate cancer screening has yet to prove its worth The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small. Can we afford the cancer care of the future? When a cancer patient and his or her doctor discuss the value of a treatment option, the conversation usually centers on a consideration of the treatment's medical benefits versus its possible side effects for the patient. Younger men with advanced prostate cancer have shorter survival times While young men with prostate cancer have a low risk of dying early, those with advanced forms of cancer do not live as long as older men with similar forms of the disease. New universal breast cancer marker predicts recurrence and clinical outcome Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival. Drugs needed to preserve eggs for reproduction need to be given in stages Cryoprotectants needed to preserve eggs for reproduction need to be given in stages, albeit rapid ones, say scientists who have developed a mathematical model that predicts optimal time for loading and unloading these drugs. More Cancer Patient Current Events and Cancer Patient News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||